The above suggests that MEOX1 may participate in the LNM process of ovarian cancer by affecting various biological behaviors, such as tumor growth, tumor EMT, ECM degradation, and lymphangiogenesis. This evidence concerns the gene MEOX1 and ovarian cancer.